Yuan Shiyun, Zhang Wenbo, Yao Qiang, Lü Wenqi, Yu Wuhan, Zhong Fuxin, Wang Yan, Xing Dianxia, Wang Xiaoqin, Song Jiaqi, Huang Hong, Chen Chenxi, Liu Junjin, Yu Weihua, Lü Yang
Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, China.
Front Aging Neurosci. 2022 Feb 10;13:762907. doi: 10.3389/fnagi.2021.762907. eCollection 2021.
The follow-up study on neuropsychiatric changes after the lifting of coronavirus disease 2019 (COVID-19) quarantine in patients with cognitive impairment and their caregivers is still lacking, and relative information is needed to formulate more comprehensive healthcare prevention measures worldwide.
To provide data on the changes in neuropsychiatric performance after the lifting of COVID-19 quarantine in patients with cognitive disorders and their caregivers.
Two surveys in Chongqing, China were conducted telephonic interview with 531 patients and their caregivers. The baseline survey was performed from February 11 to 23, 2020, and the follow-up was from October 24 to November 9, 2020. The data of neuropsychiatric symptoms (NPSs), sleep, nutrition, and chronic diseases of patients, as well as the burden of care, anxiety, and depression of caregivers were evaluated.
Significant alleviation of NPSs after the lifting of COVID-19 quarantine was observed in patients with mild cognitive impairment (MCI) and dementia (both < 0.05). Compared with baseline, the prevalence for NPSs of all participants dropped from 57.94 to 38.82%. Among NPS subdomains, apathy displayed the biggest decline at follow-up by 10.72%, followed by nighttime behavior by 8.65%. Mixed effect generalized estimation equation analysis showed significant amelioration in hallucination, depression, apathy, irritability, aberrant motor behavior, and nighttime behavior (all < 0.05), with the most prominent changes in nighttime behavior and apathy. Among the patients with unsatisfactory control of chronic disease, the medication adherence rate dropped by approximately 30% after the lifting of quarantine. More importantly, around 13% increase of care burden was observed among the caregivers at follow-up, with both depression and anxiety rising by nearly 4%.
The prolonged quarantine may exacerbate NPS in patients with memory disorders, while the care burden and mental stability of the caregivers after the pandemic should also be concerned.
对于认知障碍患者及其照料者在2019冠状病毒病(COVID-19)隔离解除后的神经精神变化的随访研究仍然缺乏,需要相关信息以在全球范围内制定更全面的医疗预防措施。
提供认知障碍患者及其照料者在COVID-19隔离解除后神经精神表现变化的数据。
在中国重庆进行了两项调查,通过电话访谈531名患者及其照料者。基线调查于2020年2月11日至23日进行,随访于2020年10月24日至11月9日进行。评估了患者的神经精神症状(NPS)、睡眠、营养和慢性病数据,以及照料者的照料负担、焦虑和抑郁情况。
在轻度认知障碍(MCI)和痴呆患者中,观察到COVID-19隔离解除后NPS有显著缓解(均P<0.05)。与基线相比,所有参与者的NPS患病率从57.94%降至38.82%。在NPS子领域中,随访时冷漠下降幅度最大,为10.72%,其次是夜间行为,下降了8.65%。混合效应广义估计方程分析显示幻觉、抑郁冷漠、易怒、异常运动行为和夜间行为有显著改善(均P<0.05),夜间行为和冷漠变化最为显著。在慢性病控制不佳的患者中,隔离解除后药物依从率下降了约30%。更重要的是,随访时照料者的照料负担增加了约13%,抑郁和焦虑均上升了近4%。
延长隔离可能会加重记忆障碍患者的NPS,同时大流行后照料者的照料负担和心理稳定性也应受到关注。